<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="884">
  <stage>Registered</stage>
  <submitdate>16/11/2005</submitdate>
  <approvaldate>17/11/2005</approvaldate>
  <actrnumber>ACTRN12605000752662</actrnumber>
  <trial_identification>
    <studytitle>Psychological factors and response to medical treatment:
Do psychological factors determine the outcome in patients with inflammatory bowel disorders and other common gastrointestinal and hepatologic disorders?</studytitle>
    <scientifictitle>The course of inflammatory bowel disease, irritable bowel syndrome and hepatitis C in relation to psychological co-morbidity - a cohort prospective management trial.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Psychological factors and response to medical treatment</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Inflammatory bowel disease (IBD)</healthcondition>
    <healthcondition>Irritable bowel syndrome (IBS)</healthcondition>
    <healthcondition>Hepatitis C (HCV)</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Inflammatory bowel disease</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Liver</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Study was a cohort prospective management study. This design enabled a comparison of the rates of psychological disorders and quality of life in IBD, IBS and HCV patients over a one-year period. The study aimed to establish whether psychological co-morbidities affect the likelihood of a successful response to treatment.</interventions>
    <comparator>Irritable bowel syndrome and chronic hepatitis C patients were controls for inflammatory bowel disease</comparator>
    <control>Active</control>
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Proportion of time in clinical remission</outcome>
      <timepoint>Over the 12 month period</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Clearance of Hepatitis C</outcome>
      <timepoint>Over the 12 month period</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Proportion of IBS patients with sufficient relief of symptoms</outcome>
      <timepoint>After a year of standard therapy</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The secondary outcome was an improvement of the psychological status and the quality of life measured on the Hospital Anxiety and Depression Scale, SCL90 and SF-12.</outcome>
      <timepoint>The secondary outcome was measured after 12 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Participants who visit the Department of Gastroenterology in Royal Adelaide Hospital (RAH) between November 2005 and April 2006 will be recruited consecutively by their doctors from IBD, IBS and Hepatitis C outpatients. Patients will be informed about the research and written consent will be obtained. Inclusion criteria Patients included into studies must satisfy any one of 1-3 AND both of 4 &amp; 5(1) Patients with IBD (Crohns disease or ulcerative colitis) diagnosed by clinical, endoscopic, histologic and/or radiologic criteria; (2) Patients with IBS diagnosed by clinical, endoscopic, histologic and/or radiologic criteria;(3) Patients diagnosed serologically with hepatitis C;(4) Patients with sufficient knowledge of English to understand and answer questionnaires;(5) Patients who sign written informed consent.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Not stated</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>(1) Patients with insufficient knowledge of English or who are cognitively impaired, as the study requires filling in and understanding questionnaires written in English;(2) Patients who do not give informed consent;(3) Hepatitis C patients with cirrhosis (other than Childs A) or cancer of the liver as, this may be confounding psychological factors, due to disease severity/known effect on mortality.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Psychosocial</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>20/11/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>275</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Adelaide</primarysponsorname>
    <primarysponsoraddress>Department of General Practice and the Department of Psychology, the University of Adelaide, Eleanor Harrald Building, Frome Rd, Adelaide 5001</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Department of General Practice and the Department of Psychology, the University of Adelaide</fundingname>
      <fundingaddress>Eleanor Harrald Building, Frome Rd, Adelaide 5001</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Department of Gastroenterology, Hepatology and General Medicine, the Royal Adelaide Hospital</fundingname>
      <fundingaddress>North Tce, Adelaide 5000, SA</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Royal Adelaide Hospital</sponsorname>
      <sponsoraddress>North Tce, Adelaide 5000, SA</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To observe and compare the course of IBD, IBS and hepatitis C in relation to psychological co-morbidity.</summary>
    <trialwebsite />
    <publication>Mikocka-Walus, A., Turnbull, D., Andrews, J., Moulding, N., Wilson, I., Holtmann, G. (2008). Does psychological status influence clinical outcomes in patients 
with inflammatory bowel disease (IBD) and other chronic gastroenterological 
diseases? An observational cohort prospective study. BioPsychoSocial Medicine 6; 2(1):11</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Royal Adelaide Hospital Research Ethics Committee,</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>The University of Adelaide Graduate Centre</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Antonina Mikocka-Walus</name>
      <address>School of Nursing and Midwiefery, University of South Australia, GPO Box 2471, Adelaide SA</address>
      <phone>+61 8 83022468</phone>
      <fax>+61 8 83022168</fax>
      <email>antonina.mikocka-walus@unisa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Antonina Mikocka-Walus</name>
      <address>School of Nursing and Midwiefery, University of South Australia, GPO Box 2471, Adelaide SA</address>
      <phone>+61 8 83022468</phone>
      <fax>+61 8 83022168</fax>
      <email>antonina.mikocka-walus@unisa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Antonina Mikocka-Walus</name>
      <address>School of Nursing and Midwiefery, University of South Australia, GPO Box 2471, Adelaide SA</address>
      <phone>+61 8 83022468</phone>
      <fax>+61 8 83022168</fax>
      <email>antonina.mikocka-walus@unisa.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>